Primary

Scholars argue that the SEC has historically resisted creating ESG disclosures but has recently changed course.

The CFTC and other regulators should evaluate with caution proposals to automate financial transactions.

Experts explore opportunities to reduce costs and promote health equity.

FDA releases new guidelines for cancer clinical trials in response to President Biden’s anti-cancer initiative.

FDA issues proposed rule that would ban menthol as a flavor additive in cigarettes.

Medical bills may continue to take consumers by surprise despite the No Surprises Act.

Court disregards the Clean Air Act’s clear language in applying the major questions doctrine to curb EPA’s climate authority.

Scholars offer approaches to improve regulation of social media marketing.

The Supreme Court increased potential intervening defendants when it implicitly protected voter ID laws.

Rejecting EPA’s ability to reshape the coal industry, the Court forecasts invalidating future agency actions.  

Calls for more deference to agency expertise derive from an unrealistic view of executive policymaking.

Several U.S. Supreme Court cases from this past term have significant implications for the provision of medical care.